lobbying_activities: 1742485

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1742485	4c6e81cd-c801-4f8e-a94b-a059e3486410	Q3	KING & SPALDING LLP	21632	SUMITOMO PHARMA AMERICA (FORMERLY SUNOVION PHARMACEUTICALS, INC.)	2015	third_quarter	PHA	Issues related to inclusion of prescription drugs within Essential Health Benefit; H.R. 2646, Helping Families in Mental Health Crisis Act of 2015; S. 1945, Mental Health Reform Act of 2015; and mental health coverage expansion	HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2015-10-19T18:29:00.380000-04:00